Adjuvant Capital Management, LLC - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 2, 2023, Adjuvant Capital Management, LLC's relationship to AN2 Therapeutics, Inc. (ANTX) is TenPercentOwner, and currently has 2,081,573 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Adjuvant Capital Management, LLC - Insider Non-Derivative Transactions of ANTX Common Stock
Adjuvant Capital Management, LLC - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 3, 2023 | Sell -- (Common Stock) | 902 | 16.07 | 393737 |
| Oct 3, 2023 | Sell -- (Common Stock) | 4770 | 16.07 | 2081573 |
| Sep 30, 2023 | Sell -- (Common Stock) | 15764 | 16.28 | 394639 |
| Sep 30, 2023 | Sell -- (Common Stock) | 83337 | 16.28 | 2086343 |
| Aug 24, 2023 | Sell -- (Common Stock) | 64 | 16 | 413092 |
| Aug 24, 2023 | Sell -- (Common Stock) | 336 | 16 | 2183888 |